Andre Terzic
Division of Cardiovascular Diseases
Department of Medicine
Mayo Clinic
Rochester
USA
Name/email consistency: high
- Channelopathies: decoding disease pathogenesis. Terzic, A., Perez-Terzic, C. Sci. Transl. Med (2010)
- Adenylate Kinase and AMP Signaling Networks: Metabolic Monitoring, Signal Communication and Body Energy Sensing. Dzeja, P., Terzic, A. Int. J. Mol. Sci (2009)
- Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Yamada, S., Nelson, T.J., Crespo-Diaz, R.J., Perez-Terzic, C., Liu, X.K., Miki, T., Seino, S., Behfar, A., Terzic, A. Stem. Cells (2008)
- Directed inhibition of nuclear import in cellular hypertrophy. Perez-Terzic, C., Gacy, A.M., Bortolon, R., Dzeja, P.P., Puceat, M., Jaconi, M., Prendergast, F.G., Terzic, A. J. Biol. Chem. (2001)
- Structural plasticity of the cardiac nuclear pore complex in response to regulators of nuclear import. Perez-Terzic, C., Gacy, A.M., Bortolon, R., Dzeja, P.P., Puceat, M., Jaconi, M., Prendergast, F.G., Terzic, A. Circ. Res. (1999)
- New frontiers of cardioprotection. Terzic, A. Clin. Pharmacol. Ther. (1999)
- Reversal of the ATP-liganded state of ATP-sensitive K+ channels by adenylate kinase activity. Elvir-Mairena, J.R., Jovanovic, A., Gomez, L.A., Alekseev, A.E., Terzic, A. J. Biol. Chem. (1996)